(Bloomberg) -- CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.Most Read from BloombergRay Dalio’s Famous Trade Is Sputtering, Investors BailingTesla Stock in ‘No Man’s Land’ After 43% Rout Ahead of EarningsBillionaire Pinaults Fight to Pull Gucci Off the Discount Rack‘Mag Seven’ Jump Minutes Away From Tesla’s Results: Markets WrapTaylor Swift Is Proof That How We Critique Music Is BrokenThe buyo